CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ranbaxy Laboratories Limited (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ranbaxy Laboratories Limited (Parent)
Village Toansa, Rail Majra
Phone: +91 1244135000p:+91 1244135000 NAWANSHAHR, 144533  India Fax: +91 1244106490f:+91 1244106490
This company was Merged or Acquired on 3/25/2015.
This is a Subsidiary, click here for the Parent Company
Business Summary
Ranbaxy Laboratories Limited (Ranbaxy) is a research-based international pharmaceutical company serving customers in over 150 countries. The Company develops, manufactures and markets generic, branded generic, value-added and over-the-counter (OTC) products, anti-retrovirals (ARVs), active pharmaceutical ingredients (APIs) and Intermediates. It has a portfolio of molecules that cover multiple dosage forms including tablets, capsules, injectables, inhalers, ointments, creams and liquids. The Company’s presence extends across therapies and includes anti-infectives, cardiovascular, pain management, central nervous system (CNS), gastrointestinal, respiratory, dermatology, orthopedics, nutritionals and urology. The Company has ground operations in 43 countries and manufacturing facilities spread across eight countries. Ranbaxy is a member of the Daiichi Sankyo Group, a Japan-based global pharmaceutical company.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20143/31/2014Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board IsraelMakov 78 1/1/2017 1/1/2017
President, Chief Financial Officer IndrajitBanerjee 57 8/24/2011 8/24/2011
Chief Executive Officer, Managing Director, Executive Director ArunSawhney 8/5/2011 8/20/2010
11 additional Officers and Directors records available in full report.

Business Names
Business Name
Basics GmbH
Be-Tabs Investments (Proprietary) Ltd.
Be-Tabs Pharmaceuticals (Proprietary) Ltd
45 additional Business Names available in full report.

General Information
Fax Number: +91 1244106490


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023